New ETF Book by Larry Connors - Click here to read more
Separately, the Company recently launched a new interactive digital prescription website allowing doctors and pharmacists to sign up online to use digiMedical's products. The new site, www.digiReAuth.com, is part of an ongoing effort by the Company to market digiRX, a thin client suite of products providing digital prescription and reauthorization services to doctors, pharmacists and patients. Utilizing the latest Microsoft technologies such as .NET, AJAX and Microsoft SQL, the Company has developed a suite of products to digitally manage the prescription process. The Company's products comply with all HIPAA and DEA requirements for patient medical record security. Dear Fellow Shareholders, In my shareholder letter released March 24th of this year, I outlined what directions digiMedical would be undertaking for 2009. Let me recap these directions for you and give you an update as to our progress. Quarter One Activity In recent months, the Company announced that it is growing its advisory board, with the most recent addition being Jason Whisenant, www.digiMedical.com/News/News.aspx. He and others like him will help expand the Company's ability to forecast future trends and marketing segments in the digital prescription industry, while at the same time improving our sales and marketing division. Over the course of the first quarter, the Company also launched our new corporate website www.digiMedical.com, detailing our proprietary digital prescription software. We also launched two other vital websites www.digiRX.com and www.digiReAuth.com. These websites allow doctors and pharmacists to find out about our products and services and sign up via the Web. These websites leverage our software and significantly expand our ability to sell to and service the market with minimal backend manpower, resulting in a strong platform allowing for exponential sales growth. Quarter Two Activity Board member Philip Verges, CEO of NewMarket Technology (PINKSHEETS: NMKT), introduced VirtualHealth (OTCBB: VHGI) and our Company. VirtualHealth has a medical practice management system software product with a large client base (for more information visit http://www.mosonline.com). I am pleased to announce a new, signed contract with VirtualHealth to offer our software and services in conjunction with their software to their client base of over 1,500 offices nationwide. This is a significant move for digiMedical to increase our sales channels and our software's visibility in the market. In the third quarter, we will contiue to work on this new sales channel to sign on more doctors. We plan to issue more information on this agreement in the future and we will continue to look for other large sales channels to partner with. Additionally, in quarter three, we are planning to roll out a new version, 3.0, of our digiRX product. Summary digiMedical is focused on expanding our market share through reselling our software products digiRX, digiReAuth and digiPRN Pharmacies by forging agreements with partners that have an existing client base and sales channels, like with VirtualHealth, that will significanlty increase our sales and visibility in the market. We recognize this is a difficult economy, and therefore perhaps a difficult time to be a development stage company. However, we are enthusiastic about our progress to date and consider our recent channel agreement, in conjunction with our already proven, in production software to be a significant milestone for the Company. I hope shareholders share our enthusiasm and if so, I would ask you spread the word. Everyone knows at least one doctor, so let them know about our products. We are proud of the products we have developed and the security and savings they have brought our clients. digiMedical is a great story, and we have set the foundations for a bright future. Thank you all for your patience and support. Best regards, David W. Lee CEO of digiMedical Solutions, Inc. To be added to digiMedical's corporate e-mail list to receive company updates, please send an e-mail to ir@digimedical.com. About digiMedical Solutions, Inc.(TM) (www.digiMedical.com) digiMedical Solutions, Inc.(TM) is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, direct marketing of the company's digital call center services for refills and reauthorization and partnering with independent pharmacy chains to focus sales with the technology suite. Forward-Looking Statement Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission. Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 ir@digimedical.com www.digimedical.com SOURCE: digiMedical Solutions, Inc. mailto:ir@digimedical.com http://www.digimedical.com For full details for DGMS click here.
Email Print Archives Feedback Email Article Link
Close X
Most Popular News
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
Premium Subscription Services
RELATED SITES
Please call 1-213-955-5858 ext. 1
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN. The Connors Group, Inc. © Copyright 2009 The Connors Group, Inc. All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy. © 2009 The Connors Group, Inc.
|
